Bizarre Patents
Pet Toilet-Like Water Disk and Food Storage
One pet-friendly inventor patented "a device for watering pets, e.g., a dog or cat." The device, he helpfully noted, "has the general shape of a toilet."
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7294503 | Microfabricated crossflow devices and methods A microfluidic device for analyzing and/or sorting biological materials (e.g., molecules such as polynucleotides and polypeptides, including proteins and enzymes; viruses and cells) and methods for its use are provided. The device and methods of the invention are us... | 11/13/2007 |
| 7034033 | Substituted quinazolinone compounds A variety of low molecular weight, guanidino-containing molecules capable of acting as MC4-R agonists are provided. The compounds are useful in treating MC4-R mediated diseases. The compounds have the structure IA, IB, or IC where the values of the variable are defi... | 04/25/2006 |
| 6960582 | Guanidino compounds Compounds having the general structure II are provided: A is selected from the group consisting of C or CH and X and Y are independently selected from the group consisting of CH2, N, C═O, C═S, (CR6 | 11/01/2005 |
| 6890907 | Methods and unit dose formulations for the inhalation administration of tobramycin A patient suffering from an endobronchial infection is treated by administering to the patient for inhalation a dose of less than about 4.0 ml of a nebulized aerosol formulation comprising from about 60 to about 200 mg/ml of an aminoglycoside antibiotic, such as tob... | 05/10/2005 |
| 6884780 | Method for increasing the serum half-life of a biologically active molecule A method is provided for preparing a biologically active molecule having an increased serum half-life. The method involves conjugating a polymer such as polyethylene glycol to the biologically active molecule. Also provided are polypeptide drugs having an increased ... | 04/26/2005 |
| 6869969 | Estrogen receptor modulators Isoxazole estrogen receptor agonist and antagonist compounds having unexpected and surprising activity in modulating estrogen receptor activity are described. In addition, methods and compositions for treating or preventing estrogen receptor-mediated disorders are d... | 03/22/2005 |
| 6846921 | Chimeric antisense oligonucleotides and cell transfecting formulations thereof Chimeric oligonucleotide of the formula 5′-W—X1—Y—X2—Z-3′, where W represents a 5′-O-alkyl nucleotide, each of X1 and X2 represents a block of seven to twelve phosphodiester-linked 2′-O-alkyl ribonucleotide... | 01/25/2005 |
| 6783929 | Biological sample component purification and differential display Provided are affinity support materials having intermediate binding affinity for biological samples. Among the materials provided by the present invention are hydrophilic solid supports composed of hydrophilic ligands coupled to hydrophilic matrixes which are compat... | 08/31/2004 |
| 6756359 | C12 modified erythromycin macrolides and ketolides having antibacterial activity Antimicrobial macrolide compounds are provided having formulas II: as well as pharmaceutically acceptable salts, esters or prodrugs thereof; pharmaceutical compositions comprising such compounds; methods of treating bact... | 06/29/2004 |
| 6727273 | Estrogen receptor modulators Estrogen receptor-modulating pyrazole compounds are described in addition to methods and compositions for treating or preventing estrogen receptor-mediated disorders. The compounds described have been found to have unexpected and surprising activity in modulating es... | 04/27/2004 |
| 6716840 | Guanidino compounds Compounds having the general structure I are provided: X and Y are independently selected from the group consisting of CH2, N, NR9, C═O, C═S, S═O, SO2, S, O, (CR6R7 | 04/06/2004 |
| 6677445 | Chimeric antisense oligonucleotides and cell transfecting formulations thereof Chimeric oligonucleotide of the formula 5'-W-X1 -Y-X2 -Z-3', where W represents a 5'-O-alkyl nucleotide, each of X1 and X2 represents a block of seven to twelve phosphodiester-linked 2'-O-alkyl ribonucleotides, ... | 01/13/2004 |
